인도의 더말 필러 시장은 2025-2032년 예측 기간 동안 CAGR 12%를 기록하며, 2024년 1억 3,146만 달러에서 2032년 3억 2,549만 달러로 성장할 것으로 예측됩니다.
미용 피부과학 분야에서 더말 필러는 뇌하수, 작은 주름, 주름을 줄이기 위해 특정 피부 영역의 볼륨을 높이는 것을 목표로 주입 가능한 재료입니다. 더말 필러는 일반적으로 콜라겐, 히알루론산 또는 합성 물질로 만들어져 젊은 외관을 주는 것을 목표로 합니다. 이 비침습적인 미용 시술은 노화의 징후를 치료하는 데 효과적이기 때문에 인기가 높아지고 있습니다. 일반적으로 수술에 수반되는 요양 기간을 견디지 않고 보다 신선한 인상을 주는 단기적인 방법입니다. 수많은 요인들이 인도의 더말 필러 산업에 큰 영향을 미치고 있습니다. 고객의 미의식이 높아지고 침습적인 시술을 선호하는 수요가 증가하고 있습니다. 또한 보다 오래 지속되고 자연스러운 마무리를 보장하는 제품 조성의 개선도 업계의 이익이 되고 있습니다. 게다가 인구의 고령화와 지출 능력의 증대가 안티에이징 제품 수요를 견인하고 있어 이것도 업계를 견인하는 요인이 되고 있습니다. 세계에서 아름다움을 향상시키는 시술의 용이성과 수용성이 높아지고 있는 것은 더말 필러 시장을 안정 성장의 궤도로 향하게 하는 주요 요인입니다.
예를 들어, 2022년 8월, Allergan Aesthetics plc(AbbVie Inc.의 일부)는 인도에서 특히 턱 라인과 턱을 위해 만들어진 히알루론산 더말 필러 Juvederm VOLUX를 발표했습니다. VOLUX는 히알루론산 25mg + 염산 리도카인 3mg의 조합으로, 특히 턱과 턱 라인에 사용하도록 설계되어 있습니다.
모든 부문은 해당 지역 및 국가에서 제공됩니다.
위의 회사는 시장 점유율을 기반으로 순위를 보유하지 않으며 조사 작업 중에 사용 가능한 정보를 기반으로 변경될 수 있습니다.
India dermal fillers market is projected to witness a CAGR of 12% during the forecast period FY2025-FY2032, growing from USD 131.46 million in FY2024 to USD 325.49 million in FY2032.
In the field of cosmetic dermatology, dermal fillers are injectable materials intended to raise the volume of certain skin regions to lessen the appearance of drooping, fine lines, and wrinkles. Dermal fillers, which are usually made of collagen, hyaluronic acid, or synthetic materials, are intended to give a youthful appearance. The efficacy of this non-invasive cosmetic procedure in treating signs of ageing has led to its increasing popularity. It gives patients a short-term way to seem more refreshed without having to endure the recuperation period typically associated with surgery. Numerous factors have a major impact on the India dermal filler industry. Customers' growing aesthetic consciousness and preference for minimally invasive procedures have led to an increase in demand. The industry also benefits from improvements in product compositions that guarantee longer-lasting and seemingly natural results. Moreover, ageing population coupled with growing expenditure capacity, has led the demand for anti-aging products, is another factor driving the industry. The increasing accessibility and acceptance of beauty-enhancing procedures around the world are major factors propelling the dermal fillers market towards a trajectory of stable growth.
For example, in August 2022, Allergan Aesthetics plc (part of AbbVie Inc.) introduced Juvederm VOLUX, a hyaluronic acid dermal filler created especially for the jawline and chin in India. VOLUX is a combination of Hyaluronic acid 25 mg + Lidocaine hydrochloride 3 mg, specifically designed for use in the chin and jawline.
Rising Consumer Awareness Boosting the Market Growth
The market for dermal fillers is expanding rapidly due to recent developments in India. Perception of cosmetic procedures is changing as a result of the growing acceptability of aesthetic treatments, especially among younger consumers. Dermal fillers have become increasingly popular as more people look for non-surgical ways to improve their faces. This trend has been aided by the growth of cosmetic clinics and medical spas in cities. Improvements in safety and efficacy brought about by technological developments in filler formulations, particularly those based on hyaluronic acid, have increased the appeal of these procedures. Furthermore, social media platforms have been playing important part in normalising cosmetic operations and persuading people that dermal fillers are a good way to improve their appearance. This tendency has been further stimulated by the growth of a middle class with more discretionary income, which enables more people to spend money on cosmetic improvements. Additionally, India's standing as a medical tourism destination is drawing in foreign patients looking for premium care at affordable costs. These elements, together with calculated partnerships between producers and clinics, are fostering a thriving dermal fillers market in India and setting it up for future growth. According to the International Society of Aesthetic Plastic Surgery data published in 2023, a total of 222,544 non-surgical injectable procedures performed in India, a significant increase from just 90,384 in 2020.
Recent Advancements to Fuel Market Growth
Advances in filler compositions, such as the advent of hyaluronic acid-based fillers with varying degrees of cross-linking, have changed the available treatment choices. Professionals can now customize their treatments to yield better, longer-lasting benefits thanks to these advancements. For instance, new biodegradable and bioresorbable fillers address sustainability concerns and appeal to environmentally conscious consumers. Additionally, the administration of dermal fillers is now more accurate and effective due to the use of advanced injectable procedures, which also shorten recovery times and minimize patient discomfort. The rise in minimally invasive procedures has further boosted demand as more people search for non-surgical options for aesthetic improvements. Furthermore, as research and development continue, projects are broadening the range of dermal filler treatments beyond conventional ones like wrinkle treatment and lip augmentation to include volume restoration and facial contouring. This continuous innovation not only drives market growth but also enhances consumer confidence in aesthetic procedures, solidifying the role of technology as a key factor in the dermal fillers market expansion. For instance, in December 2022, Gufic Biosciences Ltd. introduced a locally produced injection of botulinum toxin type A (Botox) in India. In India, Gufic Biosciences Ltd's botox will be marketed under the name "Zarbot." According to the company, one of "Zarbot's" key characteristics is that it was produced utilizing a patented method and refined strain, which leads to a thin film formulation and superior stability when compared to other botulinum toxin brands.
Influencers and Celebrities Fueling Market Growth
The market for dermal fillers in India is being driven largely by celebrities and influencers, who also have a big impact on how the general public views and accepts cosmetic operations. Prominent people who freely talk about their experiences with fillers normalize these procedures and inspire admirers to think about getting similar improvements. Their openness about their personal preferences for aesthetic changes promotes a society in which cosmetic surgery is no longer seen as taboo but rather as a way to better oneself. Fans may closely monitor the beauty modifications of their favourite celebrities through social media channels, which magnify this influence. Nowadays, a lot of people want to look like celebrities, asking for particular traits that match the style that these giants have made popular. Not just women are following this trend; male celebrities are also changing how people view beauty and masculinity, which increases the market's attractiveness. 'Additionally, as filler debates gain traction, specialists are addressing worries regarding safety and natural outcomes, which reassures prospective customers even more. Celebrity endorsements and growing consumer awareness are driving India's dermal fillers business, increasing accessibility and acceptance of aesthetic modifications across a range of demographics.
Future Market Scenario (FY2025 - FY2032F)
The dermal filler market is set to grow because of new developments in technology, life sciences, and materials research. There is a rising need for non-invasive treatments, that will boost innovation.
Furthermore, technological advancements like AI integration in laser devices are changing the field by improving image analysis and making research processes faster, which greatly supports market growth. Other than this, innovations are the supporting pillars of this ever-growing market. For instance, the Profhilo injectable therapy is a novel cosmetic procedure that has swept the beauty industry in India off its feet. Often referred to as the "injectable moisturizer," this treatment has grown in favor among those who want to look younger, more radiant, and refreshed without undergoing invasive treatments. Profhilo adopts a novel strategy by hydrating the skin from the inside out, in contrast to conventional dermal fillers, which seek to reduce wrinkles and increase volume.
Key Players Landscape and Outlook
Key players in the dermal fillers industry are utilizing strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing big-cap industry players to increase their presence and, therefore, find new opportunities in this market.
For instance, in October 2023, A. Menarini India Private Limited (often called "Menarini India"), a part of the Menarini Group, the biggest Italian biopharmaceutical company in the world and a pioneer in dermatological and cosmetics treatments, announced its entry into the Indian aesthetics market. Through a combination of specialized, well-made products and procedures, Menarini and RELIFE, which have their main offices in Italy, provide aesthetic physicians and surgeons with a holistic approach to cosmetic medicine to assist patients in attaining effortlessly beautiful skin.
For instance, in an effort to develop powerful instruments that provide the best outcomes for practitioners and patients, Prollenium Medical Technologies Inc. announced in October 2023 that it has acquired SoftFil medical devices.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.